Introduction & Mission Statement
Research Studies
Hepatitis C & IFN-alpha
Currently Enrolling

Treatment Resistant Depression

  Currently Enrolling
Chronic Fatigue Syndrome
Meditation
Early Life Stress
Mechanisms of Glucocorticoid Resistance
Drug Development and Discovery
Treatment Resources
Funding Resources
Lectures/Slides
Links
Home
     
     
 
amill Andrew Miller, M.D.

Dr. Andrew Miller is a Professor of Psychiatry and Behavioral Sciences and Director of the Mind-Body Program at the Emory University School of Medicine in Atlanta, Georgia. He is also the Director of Clinical and Molecular Psychiatric Oncology at the Winship Cancer Institute. Dr. Miller’s work focuses on the impact of the activated immune system on behavior and health. He is also interested on the role of glucocorticoid hormones in the regulation of inflammatory responses. Dr. Miller has published over 100 manuscripts in scholarly journals and has edited a book entitled “Depressive Disorders and Immunity”. Dr. Miller has several studies funded by the National Institute of Mental Health, the Centers for Disease Control and Prevention and pharmaceutical companies to examine the mechanism and treatment of depression caused by the cytokine, interferon alpha, which is used for the treatment of infectious diseases and cancer. His interferon alpha studies provide a model to understand and treat depression in the medically ill. Aside from his research endeavors, Dr. Miller is a Board Certified Psychiatrist and an examiner for the American Board of Psychiatry and Neurology. He is also the recipient of 3 teaching awards, a NARSAD Independent Investigator Award and an NIMH Research Scientist Development Award, which he has held for the past 15 years.